Hepion Pharmaceuticals’ $34.5M Follow-on Offering

Blank Rome LLP advised ThinkEquity on the deal while Sheppard Mullin advised Hepion Pharmaceuticals, Inc. ThinkEquity, a division of Fordham Financial Management, Inc., acted as underwriters’ counsel…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here